VPIM
PCVX icon

Vanguard Personalized Indexing Management’s Vaxcyte PCVX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
30,004
+4,780
+19% +$260K 0.02% 661
2025
Q4 		$1.16M Buy
25,224
+9,369
+59% +$419K 0.01% 841
2025
Q3 		$571K Buy
15,855
+3,133
+25% +$104K 0.01% 1187
2025
Q2 		$414K Buy
12,722
+5,753
+83% +$189K ﹤0.01% 1295
2025
Q1 		$263K Buy
6,969
+349
+5% +$27.9K ﹤0.01% 1399
2024
Q4 		$542K Sell
6,620
-96
-1% -$9.53K 0.01% 1075
2024
Q3 		$767K Buy
6,716
+1,866
+38% +$168K 0.01% 900
2024
Q2 		$366K Buy
4,850
+895
+23% +$60.9K 0.01% 1174
2024
Q1 		$270K Buy
3,955
+648
+20% +$44.9K 0.01% 1318
2023
Q4 		$208K Buy
+3,307
New +$172K 0.01% 1401

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return